Alleance

Atropine sulfate 0.01% · Laboratorios Sophia S.A de C.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Alleance, covering 2025-03-21 to 2025-03-21. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate the Efficacy of Alleance® (Atropine Sulfate 0.01%) as a Treatment to Delay Myopia and Axial Ocular Elongation in Children. [Phase 3]

See pricing